Other OTC - Delayed Quote • USD
Ember Therapeutics, Inc. (EMBT)
At close: September 20 at 10:02 AM EDT
Breakdown
TTM
Operating Expense
13.9300
Operating Income
-13.9300
Net Non Operating Interest Income Expense
-6.1650
Pretax Income
-20.0950
Net Income Common Stockholders
-20.0950
Diluted NI Available to Com Stockholders
-20.0950
Basic EPS
-0.01
Diluted EPS
-0.01
Basic Average Shares
3,707.5000
Diluted Average Shares
3,707.5000
Total Operating Income as Reported
-13.9300
Total Expenses
13.9300
Net Income from Continuing & Discontinued Operation
-20.0950
Normalized Income
-20.0950
Interest Expense
6.1650
Net Interest Income
-6.1650
EBIT
-13.9300
EBITDA
-13.9300
Net Income from Continuing Operation Net Minority Interest
-20.0950
Normalized EBITDA
-13.9300
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade